Sculptor Capital’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-113,500
Closed -$10.2M 344
2024
Q3
$10.2M Hold
113,500
0.17% 101
2024
Q2
$8.93M Hold
113,500
0.17% 92
2024
Q1
$9.89M Buy
113,500
+43,500
+62% +$3.71M 0.19% 79
2023
Q4
$5.77M Buy
+70,000
New +$5.33M 0.12% 102
2015
Q1
Sell
-2,072,677
Closed -$146M 636
2014
Q4
$146M Buy
+2,072,677
New +$144M 0.39% 65
2014
Q3
Sell
-3,506,474
Closed -$223M 806
2014
Q2
$224M Buy
+3,506,474
New +$213M 0.67% 41
2014
Q1
Sell
-100,171
Closed -$5.83M 784
2013
Q4
$5.75M Buy
+100,171
New +$5.68M 0.01% 536

Other funds holding MDT

Sculptor Capital's MDT Position: Q4 2024 in Review

Sculptor Capital sold out of Medtronic (MDT) in Q4 2024, closing a stake of 113,500 shares — an estimated $10.2M sold.

Sculptor Capital first reported a position in MDT in Q4 2013 and held it in 7 quarters. The position peaked at $224M in Q2 2014. 2,123 funds tracked by Wall St. Rank hold MDT as of Q4 2024.

  • Sculptor Capital reported no remaining Medtronic position as of Q4 2024 after selling out during the quarter.
  • Sculptor Capital sold 113,500 Medtronic shares in Q4 2024, an estimated $10.2M.
  • Sculptor Capital first reported a position in Medtronic in Q4 2013 and held it in 7 quarters.
  • Sculptor Capital's Medtronic position peaked at $224M in Q2 2014.
  • 2,123 funds tracked by Wall St. Rank held Medtronic as of Q4 2024.

Based on Sculptor Capital's 13F filing for Q4 2024, filed 14 Feb 2025.